There are currently no validated biomarkers which can be used to accurately diagnose
Alzheimer’s disease (AD) or to distinguish it from other dementia-causing neuropathologies. …

Gut microbiota represents a complex physiological ecosystem that influences the host health.
Alterations in the microbiome metabolism affect the body homeostasis and they have been …

Nowadays depression is considered as a systemic illness with different biological mechanisms
involved in its etiology, including inflammatory response, hypothalamic-pituitary-adrenal (…

Schizophrenia, depression and posttraumatic stress disorder (PTSD) are severe mental
disorders and complicated diagnostic entities, due to their phenotypic, biological and genetic …

The lack of knowledge about the onset and progression of Parkinson’s disease (PD)
hampers its early diagnosis and treatment. Metabolomics might shed light on the PD imprint …

In the last decade, increasing evidence has emerged linking alterations in the brain-derived
neurotrophic factor (BDNF) expression with the development of Alzheimer’s disease (AD). …

Posttraumatic stress disorder (PTSD) is a stressor-related disorder that develops in a subset
of individuals exposed to a traumatic experience. Factors associated with vulnerability to …

Escitalopram and vortioxetine are efficacious antidepressants. They directly target serotonin
(5-HT) system, but vortioxetine mechanism of action is distinct from the one of selective …

Along with the typical biochemical alterations that occur during pregnancy, certain metabolic
changes might be associated with the development of several psychiatric disorders, …

Background: Sporadic Alzheimer’s Disease (AD) is assumed to be associated with different
biological/genetic vulnerability, as well as with neuroinflammation, mediated by cytokines. …